IVF for Families Act
Latest Action
Referred to the House Committee on Ways and Means.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The IVF for Families Act (H.R. 9333) is a bill introduced in the 118th Congress aimed at addressing taxation issues related to in vitro fertilization (IVF). The bill was referred to the House Committee on Ways and Means on August 9, 2024, but no official summary or full text is publicly available. The bill falls under the policy area of taxation and appears to focus on financial or tax-related provisions concerning IVF treatments, potentially to provide tax relief or incentives for families undergoing IVF procedures.
H.R. 9333 seeks to modify tax policy related to IVF treatments but has no publicly available detailed text or summary and was referred to committee before expiring without passage.
- The bill is titled the IVF for Families Act and was introduced in the House of Representatives during the 118th Congress.
- It was referred to the House Committee on Ways and Means, which handles taxation and revenue-related legislation.
- The bill's status is marked as Failed / Expired, indicating it did not advance beyond committee consideration in the 118th Congress.
Potential beneficiaries could include families undergoing IVF treatments who might receive tax-related benefits or relief if the bill's provisions were enacted. The healthcare and fertility treatment sectors could also be indirectly affected by changes in tax policy related to IVF.
Without the full bill text or summary, it is unclear what specific tax provisions are proposed, making it difficult to assess cost implications, administrative complexity, or oversight mechanisms. Potential concerns include the fiscal impact on tax revenues, the scope of eligibility for any benefits, and the administrative burden on tax authorities.
The bill was introduced and referred to the House Committee on Ways and Means during the 118th Congress but did not progress further and expired. The referral to the Ways and Means Committee aligns with the bill's focus on taxation. No additional legislative actions or debates are recorded.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
If enacted, the bill could influence the financial accessibility of IVF treatments by altering tax liabilities, potentially affecting demand for fertility services and related healthcare providers. Changes in tax policy could also impact insurance coverage decisions and employer benefits related to fertility treatments.
The lack of publicly available full text and official summary limits transparency and public understanding of the bill's specific provisions and potential impacts. Monitoring the bill's referral to the House Committee on Ways and Means and any future reintroduction or amendments would be important for oversight. The bill's expiration without passage highlights the need for clear documentation to inform stakeholders.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.